Abstract:The murine helminth parasite Heligmosomoides polygyrus expresses a family of proteins structurally related to TGF-β Mimic 1 (TGM1), a secreted five domain protein that activates the TGF-β pathway and converts naïve T lymphocytes to immunosuppressive Tregs. TGM1 signals through the TGF-β type I and type II receptors, TβRI and TβRII, with domains 1-2 and 3 binding TβRI and TβRII, respectively, and domains 4-5 binding CD44, a co-receptor abundant on T cells. TGM6 is a homologue of TGM1 that is co-expressed with TGM1, but lacks domains 1 and 2. Herein, we show that TGM6 binds TβRII through domain 3, but does not bind TβRI, or other type I or type II receptors of the TGF-β family. In TGF-β reporter assays in fibroblasts, TGM6, but not truncated TGM6 lacking domains 4 and 5, potently inhibits TGF-β- and TGM1-induced signaling, consistent with its ability to bind TβRII but not TβRI or other receptors of the TGF-β family. However, TGM6 does not bind CD44 and is unable to inhibit TGF-β and TGM1 signaling in T cells. To understand how TGM6 binds TβRII, the X-ray crystal structure of the TGM6 domain 3 bound to TβRII was determined at 1.4 Å. This showed that TGM6 domain 3 binds TβRII through an interface remarkably similar to the TGF-β:TβRII interface. These results suggest that TGM6 has adapted its domain structure and sequence to mimic TGF-β binding to TβRII and function as a potent TGF-β and TGM1 antagonist in fibroblasts. The coexpression of TGM6, along with the immunosuppressive TGMs that activate the TGF-β pathway, may prevent tissue damage caused by the parasite as it progresses through its life cycle from the intestinal lumen to submucosal tissues and back again. ### Competing Interest Statement The authors have declared no competing interest. * ActRII : Activin receptor type II ActRIIb : Activin receptor type IIb ALK1 : Activin receptor-like kinase 1 ALK2 : Activin receptor-like kinase 2 ALK3 : Activin receptor-like kinase 3, Bone morphogenic protein receptor, type 1A ALK4 : Activin receptor-like kinase 4, Activin receptor type-1B ALK5 : Activin receptor-like kinase 5, TGF-βtype I receptor BMP : Bone morphogenic protein BMPRII : BMP type II receptor BSA : Bovine serum albumin CCP : complement control protein DMEM : Dulbecco’s modified Eagle’s medium FBS : Fetal bovine serum TGM6 : full-length TGM6 HSQC : heteronuclear single quantum correlation ITC : isothermal titration calorimetry NMR : nuclear magnetic resonance TGF-β : transforming growth factor beta TGM : TGF-β mimic TGM1 : TGF-β mimic 1 TGM1-D123 : TGF-β mimic 1 domains 1, 2, and 3 TGM1-D3 : TGF-β mimic 1 domain 3 TGM6 : TGF-β mimic 6 TGM6-D3 : TGM6 domain 3 TGM6-D45 : TGM6 domains 4 and 5 Treg : regulatory T-cell TβRII : TGF-β type II receptor

Tumor Necrosis Factor-stimulated Gene 6 (TSG-6)-mediated Interactions with the Inter-α-inhibitor Heavy Chain 5 Facilitate Tumor Growth Factor β1 (TGFβ1)-dependent Fibroblast to Myofibroblast Differentiation

Transcriptional regulation of TSG6, a tumor necrosis factor- and interleukin-1-inducible primary response gene coding for a secreted hyaluronan-binding protein

Antifibrotic TSG-6 Expression Is Synergistically Increased in Both Cells during Coculture of Mesenchymal Stem Cells and Macrophages via the JAK/STAT Signaling Pathway

TSC-22 Promotes Transforming Growth Factor Β-Mediated Cardiac Myofibroblast Differentiation by Antagonizing Smad7 Activity

Transforming Growth Factor Β Signal Transduction in Hepatic Stellate Cells Via SMAD2/3 Phosphorylation, a Pathway That is Abrogated During in Vitro Progression to Myofibroblasts

TSG-6: a pluripotent inflammatory mediator?

TSG-6 Is Involved in Fibrous Structural Remodeling after the Injection of Adipose-derived Stem Cells

TNF-alpha suppresses alpha-smooth muscle actin expression in human dermal fibroblasts: an implication for abnormal wound healing

TSG-6 Modulates the Interaction between Hyaluronan and Cell Surface CD44*[boxs]

Transforming Growth Factor-β Receptor Type I-dependent Fibrogenic Gene Program is Mediated Via Activation of Smad1 and ERK1/2 Pathways

A novel secretory tumor necrosis factor-inducible protein (TSG-6) is a member of the family of hyaluronate binding proteins, closely related to the adhesion receptor CD44

Tyrosine phosphorylation of the LDL receptor-related protein (LRP) and activation of the ERK pathway are required for connective tissue growth factor to potentiate myofibroblast differentiation.

TGF{beta} drives fibrotic remodeling via modulation of homeostatic and pathological fibroblast populations in a murine model of pulmonary fibrosis

Acute and temporal expression of tumor necrosis factor (TNF)-α-stimulated gene 6 product, TSG6, in mesenchymal stem cells creates microenvironments required for their successful transplantation into muscle tissue

Ga12 and Ga13 proteins are required for TGF-β-induced myofibroblast differentiation

TSG-6 Potentiates the Antitissue Kallikrein Activity of Inter–α-inhibitor through Bikunin Release

Recruitment of Matrix Metalloproteinase-9 (MMP-9) to the Fibroblast Cell Surface by Lysyl Hydroxylase 3 (LH3) Triggers Transforming Growth Factor-β (TGF-β) Activation and Fibroblast Differentiation*

Transforming Growth Factor-β Signaling in Fibrotic Diseases and Cancer-Associated Fibroblasts

TNF RECEPTOR-ASSOCIATED FACTOR 6(TRAF6) MEDIATES THE ANGIOTENSIN-INDUCED NON-CANONIACL TGFβ PATHWAY ACTIVATION AND DIFFERENTIATION OF C-KIT+ CARDIAC STEM CELLS

TGM6, a helminth secretory product, mimics TGF-β binding to TβRII to antagonize TGF-β signaling in fibroblasts

TSG-6 protein, a negative regulator of inflammatory arthritis, forms a ternary complex with murine mast cell tryptases and heparin